Single BioNTech/Pfizer vaccine dose reduces risk of COVID-19 by nearly 52%, matching clinical …,

Results from large-scale vaccinations match findings from clinical trials for the BioNTech/Pfizer messenger ribonucleic acid (mRNA) vaccine., Results from large-scale vaccinations match findings from clinical trials for the BioNTech/Pfizer messenger ribonucleic acid (mRNA) vaccine., Read More

Scroll to Top